Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : NNVC - NanoViricides, Inc. -- Ignore unavailable to you. Want to Upgrade?

To: Straynut who wrote (10043)	4/9/2018 8:09:13 AM
From: old 'n cranky	Read Replies (1) \| Respond to of 12873

"These drug candidates will now advance towards the full battery of GLP safety and toxicology studies that are needed for filing an Investigational New Drug (IND) application with the US FDA, prior to beginning human clinical trials." Sounds good, but still plural "candidates" and "now advance toward" GLP safety and toxicology? Will those things be changing at some point? In other words is there a goal to have a single candidate going into GLP safety and toxicology and what is standing between now advancing and actually starting? Will any further efficacy testing be done to distinguish between the candidates between now and GLP safety and toxicology? Or is it the ultimate intent to secure the approval of multiple drugs to treat the individual "alphaherpesviruses"? If the answer requires the use of the term "broad spectrum" I hope it includes a further explanation.

To: Straynut who wrote (10043)	4/13/2018 4:18:35 PM
From: BoredMember	1 Recommendation Recommended By Another_Voice_2 Read Replies (1) \| Respond to of 12873

Great News! Initial non-GLP toxicology completed! Drugs being developed for multiple indications and market size is in the 10's of Billions! Being developed for topical use at site of infection! Direct and fast. Dr. Eugene Seymour left us in great shape. His dedication, commitment, and tireless hours of hard work will finally pay off for us. We should all thank him for his efforts, successes and never ending desire to keep us and the world aware of all the great progress Nanoviricides is making. Thank you Dr. Eugene Seymour! This is our year!